choiyizhang
2022-01-19
Ok
BioNTech shares tumbled nearly 8% in morning trading<blockquote>BioNTech股价早盘暴跌近8%</blockquote>
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":697431677,"tweetId":"697431677","gmtCreate":1642555276023,"gmtModify":1642555276299,"author":{"id":3569478830719997,"idStr":"3569478830719997","authorId":3569478830719997,"authorIdStr":"3569478830719997","name":"choiyizhang","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":18,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Ok</p></body></html>","htmlText":"<html><head></head><body><p>Ok</p></body></html>","text":"Ok","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/697431677","repostId":1159142841,"repostType":4,"repost":{"id":"1159142841","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1642516584,"share":"https://www.laohu8.com/m/news/1159142841?lang=zh_CN&edition=full","pubTime":"2022-01-18 22:36","market":"us","language":"en","title":"BioNTech shares tumbled nearly 8% in morning trading<blockquote>BioNTech股价早盘暴跌近8%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1159142841","media":"Tiger Newspress","summary":"BioNTech shares tumbled nearly 8% in morning trading. Israel sticks with 4th vaccine shot, sees Omic","content":"<p><html><head></head><body>BioNTech shares tumbled nearly 8% in morning trading. Israel sticks with 4th vaccine shot, sees Omicron waning in a week.<img src=\"https://static.tigerbbs.com/820a316803b5a9c6361c44c1007ab003\" tg-width=\"865\" tg-height=\"641\" width=\"100%\" height=\"auto\"/>Israel will continue to offer a fourth COVID-19 vaccine shot despite preliminary findings that it is not enough to prevent Omicron infections, a senior health official said on Tuesday, predicting contagions stoked by the variant will wane in a week.</p><p><blockquote><html><head></head><body>BioNTech股价早盘下跌近8%。以色列坚持第四次疫苗注射,预计奥密克戎将在一周内减弱。以色列一名高级卫生官员周二表示,尽管初步发现不足以预防奥密克戎病毒感染,但以色列将继续提供第四剂COVID-19疫苗,并预测该变种引发的传染病将在一周内减弱。</body></html></blockquote></p><p>The fastest country to roll out vaccinations a year ago, Israel last month started offering a fourth shot - also known as a second booster - to its most vulnerable and high-risk groups.</p><p><blockquote>以色列是一年前推出疫苗接种最快的国家,上个月开始向其最脆弱和高危人群提供第四针(也称为第二针加强针)。</blockquote></p><p>A preliminary study published by an Israeli hospital on Monday found that the fourth shot increases antibodies to even higher levels than the third but "probably" not enough to fend off the highly transmissible Omicron.</p><p><blockquote>以色列一家医院周一发表的一项初步研究发现,第四针将抗体增加到比第三针更高的水平,但“可能”不足以抵御高传播性奥密克戎。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech shares tumbled nearly 8% in morning trading<blockquote>BioNTech股价早盘暴跌近8%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech shares tumbled nearly 8% in morning trading<blockquote>BioNTech股价早盘暴跌近8%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2022-01-18 22:36</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><head></head><body>BioNTech shares tumbled nearly 8% in morning trading. Israel sticks with 4th vaccine shot, sees Omicron waning in a week.<img src=\"https://static.tigerbbs.com/820a316803b5a9c6361c44c1007ab003\" tg-width=\"865\" tg-height=\"641\" width=\"100%\" height=\"auto\"/>Israel will continue to offer a fourth COVID-19 vaccine shot despite preliminary findings that it is not enough to prevent Omicron infections, a senior health official said on Tuesday, predicting contagions stoked by the variant will wane in a week.</p><p><blockquote><html><head></head><body>BioNTech股价早盘下跌近8%。以色列坚持第四次疫苗注射,预计奥密克戎将在一周内减弱。以色列一名高级卫生官员周二表示,尽管初步发现不足以预防奥密克戎病毒感染,但以色列将继续提供第四剂COVID-19疫苗,并预测该变种引发的传染病将在一周内减弱。</body></html></blockquote></p><p>The fastest country to roll out vaccinations a year ago, Israel last month started offering a fourth shot - also known as a second booster - to its most vulnerable and high-risk groups.</p><p><blockquote>以色列是一年前推出疫苗接种最快的国家,上个月开始向其最脆弱和高危人群提供第四针(也称为第二针加强针)。</blockquote></p><p>A preliminary study published by an Israeli hospital on Monday found that the fourth shot increases antibodies to even higher levels than the third but "probably" not enough to fend off the highly transmissible Omicron.</p><p><blockquote>以色列一家医院周一发表的一项初步研究发现,第四针将抗体增加到比第三针更高的水平,但“可能”不足以抵御高传播性奥密克戎。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159142841","content_text":"BioNTech shares tumbled nearly 8% in morning trading. Israel sticks with 4th vaccine shot, sees Omicron waning in a week.Israel will continue to offer a fourth COVID-19 vaccine shot despite preliminary findings that it is not enough to prevent Omicron infections, a senior health official said on Tuesday, predicting contagions stoked by the variant will wane in a week.The fastest country to roll out vaccinations a year ago, Israel last month started offering a fourth shot - also known as a second booster - to its most vulnerable and high-risk groups.A preliminary study published by an Israeli hospital on Monday found that the fourth shot increases antibodies to even higher levels than the third but \"probably\" not enough to fend off the highly transmissible Omicron.","news_type":1,"symbols_score_info":{"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":2221,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/697431677"}
精彩评论